Business Description
Zhejiang Chemsyn Pharm Co Ltd
ISIN : CNE100006CY8
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.97 | |||||
Interest Coverage | 5401.25 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 37.87 | |||||
Beneish M-Score | -2.17 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year EBITDA Growth Rate | -0.9 | |||||
3-Year FCF Growth Rate | -31 | |||||
3-Year Book Growth Rate | 8.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.04 | |||||
9-Day RSI | 41.29 | |||||
14-Day RSI | 40.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 28.69 | |||||
Quick Ratio | 27.08 | |||||
Cash Ratio | 24.64 | |||||
Days Inventory | 106.57 | |||||
Days Sales Outstanding | 59.89 | |||||
Days Payable | 48.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.54 | |||||
Operating Margin % | 43.38 | |||||
Net Margin % | 40.34 | |||||
FCF Margin % | 7.53 | |||||
ROE % | 23.08 | |||||
ROA % | 21.71 | |||||
ROIC % | 43.81 | |||||
ROC (Joel Greenblatt) % | 70.62 | |||||
ROCE % | 26.09 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 11.18 | |||||
PE Ratio without NRI | 11.15 | |||||
Shiller PE Ratio | 15.92 | |||||
Price-to-Owner-Earnings | 30.47 | |||||
PEG Ratio | 0.3 | |||||
PS Ratio | 4.51 | |||||
PB Ratio | 1.73 | |||||
Price-to-Tangible-Book | 1.79 | |||||
Price-to-Free-Cash-Flow | 51.64 | |||||
Price-to-Operating-Cash-Flow | 17.11 | |||||
EV-to-EBIT | 11.05 | |||||
EV-to-EBITDA | 10.39 | |||||
EV-to-Revenue | 5.05 | |||||
EV-to-FCF | 67 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.4 | |||||
Price-to-Graham-Number | 0.94 | |||||
Price-to-Net-Current-Asset-Value | 2.23 | |||||
Price-to-Net-Cash | 2.61 | |||||
Earnings Yield (Greenblatt) % | 9.05 | |||||
FCF Yield % | 1.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zhejiang Chemsyn Pharm Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 199.204 | ||
EPS (TTM) (Â¥) | 1.27 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 40.82 | ||
14-Day ATR (Â¥) | 0.284117 | ||
20-Day SMA (Â¥) | 14.3945 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (Â¥) | 13.91 - 19.91 | ||
Shares Outstanding (Mil) | 80 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang Chemsyn Pharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang Chemsyn Pharm Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang Chemsyn Pharm Co Ltd Frequently Asked Questions
What is Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656)'s stock price today?
When is next earnings date of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656)?
Does Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |